Could antigen tests help control COVID-19 transmission in workplaces?
EU-OSHA has joined forces with the European Centre for Disease Prevention and Control (ECDC) to explore the use of rapid antigen diagnostic tests for SARS-CoV-2, the virus that causes COVID-19, in occupational settings.
The findings are presented in a new technical report, which includes a survey of EU-OSHA’s focal points on the use of rapid antigen tests in a workplace context. The report shows that rapid antigen testing can help to reduce the spread of the virus in high-risk indoor workplaces. However, the report stresses that testing cannot replace other safety and health measures and should be used to complement them.
It also highlights the importance of involving employers, workers, occupational safety and health authorities, public health authorities and occupational health services in the design of a testing strategy for the workplace before implementation.
Read the report: Considerations on the use of rapid antigen detection (including self-) tests for SARS-CoV-2 in occupational settings
Other News
Featured Supplier
Stago’s objective is to improve the health of as many people as possible by offering powerful biotechnology solutions for blood-based diagnostics.
We take a lean, confidence-building approach to digital connectivity – from our latest Coag.One middleware to our cyber-secure Connect.One capability for enhanced engineering and remote...
Upcoming Events
Lab Innovations 2021
NEC, Birmingham
3-4 November 2021
IBMS Biomedical Science Congress 2022
International Convention Centre, Birmingham
14-17 March 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
